CME Breakfast Symposium
7:00 AM – 11:00 AM
Hyatt Regency Orlando
Regency Ballroom R
9801 International Drive
Orlando, FL 32819
PROGRAM AGENDA
FACULTY PANEL
TARGET AUDIENCE
This activity is designed to meet the educational needs of hematologists, oncologists, and other healthcare professionals involved in the diagnosis and treatment of patients with blood cancers.
EDUCATIONAL OBJECTIVES
After completing this activity, participants should be better able to:
CONTINUING MEDICAL EDUCATION INFORMATION
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine, The Leukemia & Lymphoma Society, and RMEI Medical Education LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
FEE INFORMATION
There is no fee for this educational activity.
AMERICANS WITH DISABILITIES ACT
STATEMENT OF SUPPORT
This activity is jointly provided by The Leukemia & Lymphoma Society, RMEI Medical Education, LLC, and Postgraduate Institute for Medicine.
The educational portion of this program is supported by independent educational grants from Amgen, AstraZeneca Pharmaceuticals LP, and Celgene Corporation. Additional funding provided by The Leukemia & Lymphoma Society.
For information on leukemia, lymphoma, or myeloma, contact an LLS Information Specialist at (800) 955-4572 or infocenter@LLS.org, or visit www.LLS.org.